Sangamo Therapeutics (LTS:0R1D) Accounts Payable : $15.47 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sangamo Therapeutics Accounts Payable?

Sangamo Therapeutics's Accounts Payable for the quarter that ended in Mar. 2024 was $15.47 Mil.

Sangamo Therapeutics's quarterly Accounts Payable declined from Sep. 2023 ($15.46 Mil) to Dec. 2023 ($15.26 Mil) but then increased from Dec. 2023 ($15.26 Mil) to Mar. 2024 ($15.47 Mil).

Sangamo Therapeutics's annual Accounts Payable increased from Dec. 2021 ($9.76 Mil) to Dec. 2022 ($22.42 Mil) but then declined from Dec. 2022 ($22.42 Mil) to Dec. 2023 ($15.26 Mil).

Sangamo Therapeutics Accounts Payable Historical Data

The historical data trend for Sangamo Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangamo Therapeutics Accounts Payable Chart

Sangamo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

6.67

12.55

9.76

22.42

15.26

Sangamo Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															19.92	14.84	15.46	15.26	15.47

Sangamo Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Sangamo Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Sangamo Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangamo Therapeutics (LTS:0R1D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

SGMO:USA GBY:Germany

Address

7000 Marina Boulevard, Brisbane, CA, USA, 94005

Website

https://www.sangamo.com

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Sangamo Therapeutics (LTS:0R1D) Headlines

No Headlines